glucagon has been researched along with labetalol in 8 studies
| Studies (glucagon) | Trials (glucagon) | Recent Studies (post-2010) (glucagon) | Studies (labetalol) | Trials (labetalol) | Recent Studies (post-2010) (labetalol) |
|---|---|---|---|---|---|
| 26,039 | 1,498 | 3,054 | 1,980 | 450 | 327 |
| Protein | Taxonomy | glucagon (IC50) | labetalol (IC50) |
|---|---|---|---|
| Beta-2 adrenergic receptor | Homo sapiens (human) | 0.016 | |
| Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | 3.354 | |
| Beta-1 adrenergic receptor | Homo sapiens (human) | 0.01 | |
| Cytochrome P450 2D6 | Homo sapiens (human) | 0.8 | |
| 5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 0.393 | |
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 3.354 | |
| Alpha-1D adrenergic receptor | Homo sapiens (human) | 0.521 | |
| 5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | 0.393 | |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 3.037 | |
| Sodium-dependent dopamine transporter | Homo sapiens (human) | 1.607 | |
| Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) | 1.815 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (25.00) | 18.7374 |
| 1990's | 4 (50.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Danby, P; Edmunds, ME; Feehally, J; Korzets, A; Walls, J | 1 |
| Armario, A; Garvey, JS; Hidalgo, J | 1 |
| Allonen, H; Arola, M; Laaksonen, VO; Meretoja, OA | 1 |
| Guillet, R; Stevens, TP | 1 |
| Amar, D; Frishman, WH; Lazar, EJ; Shamoon, H | 1 |
| Crooks, BN; Deshpande, SA; Hall, C; Milligan, DW; Platt, MP | 1 |
| Bhargava, KK; Gupta, S; Ito, Y; McCuskey, RS; Palestro, CJ; Rajvanshi, P; Slehria, S; Sokhi, RP | 1 |
| Chawla, N; Kim, RK; Legler, A | 1 |
2 trial(s) available for glucagon and labetalol
| Article | Year |
|---|---|
Combined alpha- and beta-blockade with labetalol in post-open heart surgery hypertension. Reversal of hemodynamic deterioration with glucagon.
Topics: Adult; Blood Pressure; Cardiac Output; Cardiac Surgical Procedures; Clinical Trials as Topic; Depression, Chemical; Ethanolamines; Female; Glucagon; Heart Rate; Hemodynamics; Humans; Hypertension; Injections, Intravenous; Intraoperative Period; Labetalol; Male; Middle Aged; Vascular Resistance | 1980 |
Acute hyperglycaemic effect of anaesthetic induction with thiopentone.
Topics: Acute Disease; Anesthesia, Intravenous; Blood Glucose; Epinephrine; Female; Glucagon; Humans; Hyperglycemia; Insulin; Labetalol; Neurosecretory Systems; Norepinephrine; Placebos; Thiopental | 1993 |
6 other study(ies) available for glucagon and labetalol
| Article | Year |
|---|---|
Acute renal failure associated with a labetalol overdose.
Topics: Acute Kidney Injury; Adult; Drug Overdose; Glucagon; Humans; Labetalol; Male; Renal Dialysis | 1990 |
The role of catecholamines and glucagon on serum and liver metallothionein response to restraint stress.
Topics: Animals; Catecholamines; Glucagon; Labetalol; Liver; Male; Metallothionein; Propranolol; Rats; Rats, Inbred Strains; Restraint, Physical; Zinc | 1987 |
Use of glucagon to treat neonatal low-output congestive heart failure after maternal labetalol therapy.
Topics: Adult; Eclampsia; Female; Glucagon; Heart Failure; Humans; Infant, Newborn; Infant, Newborn, Diseases; Infant, Premature; Labetalol; Maternal Welfare; Mothers; Pregnancy; Treatment Outcome | 1995 |
Adverse neonatal effects of maternal labetalol treatment.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adult; Cardiomegaly; Dobutamine; Dopamine; Drug Therapy, Combination; Fatal Outcome; Female; Glucagon; Humans; Infant, Newborn; Labetalol; Norepinephrine; Pericardial Effusion; Pregnancy; Pregnancy Complications, Cardiovascular; Prenatal Exposure Delayed Effects | 1998 |
Hepatic sinusoidal vasodilators improve transplanted cell engraftment and ameliorate microcirculatory perturbations in the liver.
Topics: Adrenergic alpha-Antagonists; Animals; Calcitonin Gene-Related Peptide; Calcium Channel Blockers; Dipeptidyl Peptidase 4; Glucagon; Hepatocytes; Labetalol; Liver; Liver Circulation; Microcirculation; Nifedipine; Nitroglycerin; Phentolamine; Rats; Rats, Inbred F344; Rats, Mutant Strains; Splanchnic Circulation; Vasodilator Agents | 2002 |
Glucagon-induced hypertensive emergency: a case report.
Topics: Antihypertensive Agents; Emergencies; Female; Gastrointestinal Agents; Glucagon; Humans; Hydralazine; Hypertension; Labetalol; Middle Aged; Nitroglycerin; Vasodilator Agents | 2016 |